Form 4 for HBIO HARVARD BIOSCIENCE INC
Accepted 2025-03-21 00:00:00 ET · period of report 2025-03-19 · accession 0001104659-25-026702 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-21 | 2025-03-19 | HBIO | Green James W | CEO, Dir | F - Tax | $0.69 | -38.4K | 2.85M | -1% | -$26.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-19 | F | D | 38,413 | $0.69 | 2,845,088 | D | — | — | (F1) The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit ("RSU") awards previously granted to the Reporting Person that vested on March 19, 2025. (F2) Includes (a) 117,713 RSUs that will vest on December 29, 2025, (b) 143,198 RSUs that will vest in two equal installments on March 19, 2026 and 2027, (c) 554,407 RSUs with performance based vesting conditions and (d) 2,029,770 shares of common stock beneficially owned by the Reporting Person. |